drugset / Trial / NCT03750656
Use of Hyoscyamine Versus Tamsulosin for Management of Ureteral Stent Irritation
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of this project is to compare the efficacy of hyoscyamine to tamsulosin monotherapy in treating lower urinary tract symptoms in patients with indwelling double-J ureteral stents.
Timeline
- Start
- 2018-11-12
- Primary completion
- 2020-08-31
- Completion
- 2020-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hyoscyamine | Small molecule | 0.125 mg | Other |
| Comparator | Tamsulosin | Other / unclassified | 0.4 mg | Oral |
Indications
No indication recorded.